JCR Pharmaceuticals Co., Ltd.

TSE:4552 주식 보고서

시가총액: JP¥84.8b

JCR Pharmaceuticals 과거 수익 실적

과거 기준 확인 0/6

JCR Pharmaceuticals's earnings have been declining at an average annual rate of -0.3%, while the Pharmaceuticals industry saw earnings growing at 3.4% annually. Revenues have been growing at an average rate of 9.5% per year.

주요 정보

-0.3%

수익 성장률

-0.5%

EPS 성장률

Pharmaceuticals 산업 성장3.4%
매출 성장률9.5%
자기자본 수익률-0.7%
순이익-1.2%
최근 수익 업데이트30 Sep 2024

최근 과거 실적 업데이트

Recent updates

JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00

Sep 06
JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00

What JCR Pharmaceuticals Co., Ltd.'s (TSE:4552) 32% Share Price Gain Is Not Telling You

Sep 04
What JCR Pharmaceuticals Co., Ltd.'s (TSE:4552) 32% Share Price Gain Is Not Telling You

JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00

Aug 23
JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00

JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00

Aug 09
JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00

Earnings Miss: JCR Pharmaceuticals Co., Ltd. Missed EPS By 90% And Analysts Are Revising Their Forecasts

Aug 03
Earnings Miss: JCR Pharmaceuticals Co., Ltd. Missed EPS By 90% And Analysts Are Revising Their Forecasts

JCR Pharmaceuticals (TSE:4552) Will Pay A Dividend Of ¥10.00

Jul 26
JCR Pharmaceuticals (TSE:4552) Will Pay A Dividend Of ¥10.00

JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00

Jul 12
JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00

JCR Pharmaceuticals Co., Ltd. (TSE:4552) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

May 22
JCR Pharmaceuticals Co., Ltd. (TSE:4552) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00

Mar 18
JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00

JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00

Feb 29
JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00

수익 및 비용 분석

JCR Pharmaceuticals 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

TSE:4552 수익, 비용 및 수입 (JPY Millions )
날짜수익수익G+A 비용R&D 비용
30 Sep 2435,256-43714,05811,234
30 Jun 2440,2084,09824,7080
31 Mar 2442,8715,50712,48511,234
31 Dec 2341,3655,36414,3218,802
30 Sep 2343,0348,06313,1728,802
30 Jun 2335,5454,01411,9218,802
31 Mar 2334,3433,77211,6788,802
31 Dec 2237,5085,15413,2677,175
30 Sep 2238,2806,23513,2527,175
30 Jun 2250,87514,34313,9437,175
31 Mar 2251,08214,50713,5117,175
31 Dec 2150,93116,54914,0715,360
30 Sep 2147,51714,89912,7715,360
30 Jun 2134,7177,65710,4835,360
31 Mar 2130,0856,8928,6245,360
31 Dec 2026,1284,1377,2435,997
30 Sep 2024,4962,9836,6855,997
30 Jun 2024,8073,0767,3965,997
31 Mar 2024,7812,6787,6385,997
31 Dec 1925,7093,6538,9094,354
30 Sep 1924,1213,2609,0004,354
30 Jun 1923,6383,8027,8024,354
31 Mar 1923,1603,7157,2714,354
31 Dec 1820,8742,4547,1774,211
30 Sep 1820,6822,5666,7454,211
30 Jun 1820,8852,8576,6424,211
31 Mar 1820,5943,0706,4704,211
31 Dec 1720,2332,9306,5024,071
30 Sep 1719,7382,7226,3874,071
30 Jun 1718,6702,0796,0954,071
31 Mar 1718,0851,8635,9204,071
31 Dec 1617,4831,6686,0613,348
30 Sep 1617,1901,7515,5113,348
30 Jun 1617,0911,6205,6183,348
31 Mar 1617,4381,7895,4783,348
31 Dec 1517,5942,2995,3833,334
30 Sep 1517,4822,2815,4053,334
30 Jun 1517,1921,8615,6783,334
31 Mar 1516,8551,6825,7133,334
31 Dec 1416,3801,0666,7922,202
30 Sep 1416,5161,3196,8952,202
30 Jun 1416,1171,3166,2802,202
31 Mar 1415,7051,2966,1162,202
31 Dec 1315,6691,5176,2691,991

양질의 수익: 4552 is currently unprofitable.

이익 마진 증가: 4552 is currently unprofitable.


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: 4552 is unprofitable, and losses have increased over the past 5 years at a rate of 0.3% per year.

성장 가속화: Unable to compare 4552's earnings growth over the past year to its 5-year average as it is currently unprofitable

수익 대 산업: 4552 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (38.7%).


자기자본 수익률

높은 ROE: 4552 has a negative Return on Equity (-0.71%), as it is currently unprofitable.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기